USPTO Patent Grant: Bone Fracture Recovery Composition Manufacturing Method

The United States Patent and Trademark Office (USPTO) has issued patent US12582686B2 for a method of manufacturing a composition intended to accelerate bone fracture healing. The patent details a process that includes combining specific botanical ingredients such as Angelica gigas, Cnidium officinale, and myrrh, followed by aging, smoking, drying, grinding, and liquid extraction.

This patent grant signifies the approval of a novel manufacturing process for a therapeutic composition. While patents do not impose regulatory obligations on other entities, they protect intellectual property. Companies operating in the pharmaceutical or medical device sectors, particularly those involved in orthopedic treatments or natural product formulations, should be aware of this granted patent as it may affect their own research, development, and commercialization strategies in this specific area.